Companies
why Monopar Therapeutics Inc [MNPR] is a Good Choice for Investors After New Price Target of $8.50
Monopar Therapeutics Inc [NASDAQ: MNPR] price surged by 16.07 percent to reach at $0.18. The company report on February 22, 2024 at 7:00 AM that Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers. Figure 1. The one-year MNPR stock forecast
